Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.69 |
| ▸ | NFE2L2 | Q16236 | 4/20 | 0.63 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.63 |
| ▸ | MAOA | P21397 | 2/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | CHAT | P28329 | 2/20 | 0.57 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | RELA | Q04206 | 2/20 | 0.55 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.55 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.55 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.52 |
| ▸ | TNKS | O95271 | 1/20 | 0.52 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (Z)-1,2-Diphenylethene SCHEMBL21437321 | 1.00 | MAOB (0.69) | MAOBNFE2L2CYP19A1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL22634166 | 1.00 | MAOB (0.69) | MAOBNFE2L2CYP19A1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL9134305 | 0.96 | MAOB (0.73) | MAOBNFE2L2CYP19A1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL21847984 | 0.96 | MAOB (0.73) | MAOBNFE2L2CYP19A1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL9488270 | 0.96 | MAOB (0.73) | MAOBNFE2L2CYP19A1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL443 | 0.96 | MAOB (0.73) | MAOBNFE2L2CYP19A1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL9488275 | 0.96 | MAOB (0.73) | MAOBNFE2L2CYP19A1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL22712863 | 0.96 | MAOB (0.73) | MAOBNFE2L2CYP19A1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL347707 | 0.96 | MAOB (0.73) | MAOBNFE2L2CYP19A1MAOAMEN1 | |
| (Z)-1,2-Diphenylethene SCHEMBL9134296 | 0.96 | MAOB (0.73) | MAOBNFE2L2CYP19A1MAOAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11866416-B2 | Streptococcus mutans glucosyl transferase inhibitors for dental caries therapy | UAB RESEARCH FOUNDATION (US) | 2024-01-09 | — | — | US | disclosed |
| US-20210115007-A1 | STREPTOCOCCUS MUTANS GLUCOSYL TRANSFERASE INHIBITORS FOR DENTAL CARIES THERAPY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-04-22 | — | — | US | disclosed |
| WO-2019195430-A1 | STREPTOCOCCUS MUTANS GLUCOSYL TRANSFERASE INHIBITORS FOR DENTAL CARIES THERAPY | UAB RESEARCH FOUNDATION (US) | 2019-10-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11866416-B2 | Streptococcus mutans glucosyl transferase inhibitors for dental caries therapy | UGGT1, UGCG, GLA | MAOB 1679/4885NFE2L2 2425/4885CYP19A1 4572/4885 |
| US-20210115007-A1 | STREPTOCOCCUS MUTANS GLUCOSYL TRANSFERASE INHIBITORS FOR DENTAL CARIES THERAPY | UGGT1, UGCG, GLA | MAOB 1679/4885NFE2L2 2425/4885CYP19A1 4572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.